コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rom 44,230 cases of respiratory illness that were tested for 11 taxonomically broad groups of respira
12 C) parameters and arterial tumor enhancement were tested for ability to characterize gastroenteropanc
13 nmental constraints, this hypothesis has not been tested for acoustic signalling across a wide range
14 mmended care was observed; only 388 patients were tested for allergic bronchopulmonary aspergillosis
16 vel should be measured; patients should also be tested for anti-tissue transglutaminase, IgA against
20 HR) for psychosis and 116 healthy volunteers were tested for antibodies against multiple neuronal ant
25 GWAS) through which millions of variants can be tested for association in thousands of individuals.
26 A variant at chromosome 9p21 (rs1333049) was tested for association with subsequent events during
27 published meta-GWAS summary statistics, and were tested for association with 882 clinical diagnoses
28 396 autosomal intellectual disability genes were tested for association with ADHD risk through gene
29 gnificant SNPs previously associated with EA were tested for association with alcohol use behaviors.
31 t loci (eQTLs) of the glucose response genes were tested for association with diabetic retinopathy.
32 ntified from genome-wide association studies were tested for association with disease severity using
35 ration Environmental Sample Processor (ESP), was tested for autonomous analysis of eDNA from four com
42 des brunneus, and 35 Dermacentor variabilis) were tested for Borrelia spp., Rickettsia spp., Ehrlichi
43 o their unmutated germline precursors, which were tested for both binding to AQP4 and poly- or autore
47 as sole nitrogen source (inducing for nitA) were tested for Cas9 and sgRNA expression, and for the a
52 tal cases with suspected arbovirus infection were tested for CHIKV, dengue (DENV) and Zika virus (ZIK
54 ed for clinical trachoma, conjunctival swabs were tested for chlamydial infection using GeneXpert pla
56 ibitors based on diaryl phosphonate warheads was tested for ClpP inhibition, and a chemical explorati
57 tment, or hydrolysates of cow whey proteins, were tested for CML levels using a commercially availabl
58 reas, liver, and composite tissue recipients were tested for CMV-specific CD8+ T cells immune compete
60 hree months after ICU-discharge participants were tested for cognitive function by a neuropsychologis
61 constant optimization, which formulas should be tested for comparison, refraction measurement (testin
63 The engineered multifunctional protein C2C was tested for control of sensory neuron activity by tar
65 n and 2-4 to 12-24 hours after NIV start and were tested for correlation with outcomes.Measurements a
68 nd 23 April 2020, 3477 symptomatic employees were tested for COVID-19 at 2 employee testing centers;
69 ic data from 4,759 hospitalised patients who were tested for COVID-19 between 5 March 2020 and 12 May
71 ary 8 and July 22, 2020, 254,595 individuals were tested for COVID-19, of whom 16,317 tested positive
72 ul) receiving CD4 count testing, whole blood was tested for CrAg by CryptoPS and the IMMY LFA; the tw
73 creased among PWH; however, only half of MSM were tested for CT or GC during 2016-2017 and < 1/3 of t
74 reased among PLWH; however, only half of MSM were tested for CT or GC during 2016-2017 and less than
75 es treated with various stimulants and drugs were tested for cytokine gene and protein expression.
76 etry, and two commonly used flavor chemicals were tested for cytotoxicity with the MTT assay using hu
79 ese two functionally distinct subpopulations were tested for differences in gene expression using a g
85 ere separated into fractions DP4-DP12, which were tested for elicitor and priming activities in rice
87 ion procedures, modules of selected interest were tested for enrichment in biological ontologies, for
99 Familial Hypercholesterolemia Cohort Study) were tested for genetic FH and elevated Lp(a) via an est
100 463 individuals in the UK Biobank cohort who were tested for genetic susceptibility to esophageal ade
101 drug-induced haemolysis, all patients should be tested for glucose-6-phosphate dehydrogenase (G6PD) d
104 e CVD 103-HgR among 93 healthy Malian adults were tested for H. pylori IgG antibodies and PGI and PGI
107 icipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface antigen
108 sample included adults aged 18-49 years who were tested for HBV and reported at least 1 of the follo
110 45 through 1965 (baby boomers) who had never been tested for HCV and were followed through May 2018.
114 g regular immunoglobulin replacement therapy were tested for HEV RNA and anti-HEV immunoglobulin G (I
115 od samples through 100 days in the PET group were tested for HHV-6 viremia using a real-time quantita
116 ast year was associated with PWID not having been tested for HIV in the past year (adjusted prevalenc
120 [55%] women]), among whom 940 (9%) had never been tested for HIV, and among those who had been tested
123 er a period of 16 months, 12,575 individuals were tested for HIV, resulting in 33 (0.26%) new HIV dia
129 fined subcutaneous AIT form (Alutard SQ 510) were tested for IgE and IgG reactivity to 15 microarraye
130 nto microarray slides, and patients' samples were tested for IgE and IgG4 binding using immunofluores
131 re-vaccination and one-week post-vaccination was tested for IgG antibodies to Pf circumsporozoite pro
132 chain reaction (RT-PCR) test result and who were tested for IgG antibodies to SARS-CoV-2 spike prote
133 OVID-19) cases and from the pre-COVID-19 era were tested for IgG, IgA, and IgM to the antigen panel.
134 ve different commercial preparations of IVIg were tested for IgM and IgG binding to red blood cells (
136 en prevaccination and 1 week postvaccination was tested for immunoglobulin G antibodies to P. falcipa
146 ce assay, and flow cytometry, and antibodies were tested for inhibition of parasite binding to CSA.
147 S: Indonesian household contacts of TB cases were tested for interferon-gamma release assay (IGRA) co
150 een barley young leaves aqueous extract (GB) was tested for its capacity to ameliorate cellular oxida
153 erties of RvD1 and macrophage depletion (CL) were tested for its ability to slow post-traumatic OA (P
161 MRSA) in 2007 in which acute care inpatients are tested for MRSA carriage on admission, unit-to-unit
162 ver, in clinical practice, not every patient is tested for MSI, because this requires additional gene
163 2015 with locally advanced rectal cancer who were tested for MSI and treated definitively with chemor
164 Baseline and post-treatment plasma samples were tested for mutations in viral genes UL97, UL54 and/
167 rial (ClinicalTrials.gov number NCT01248195) were tested for NMDAR IgG antibodies using a live cell-b
168 The catalytic performance of ENIL materials was tested for NO conversion at different conditions.
169 y collected between ages 1-2 and 9-12 months were tested for non-toxigenic and toxigenic C. difficile
170 t for clinician-requested diagnostic testing were tested for norovirus, and positive samples were gen
177 irmed to be antagonistic to C. elegans, they were tested for pathogenicity against Meloidogyne chitwo
179 in disease pathogenesis, which are currently being tested for patients with AD across the disease spe
184 e importance in projection (VIP) score >=2.5 were tested for predictability in the "testing" set base
189 om 1,522 Indian individuals, and a framework was tested for projecting individuals onto this static a
190 with >= pAMR1 (n = 43) and non-AMR (n = 21) were tested for reactivity against a panel of 44 non-HLA
193 ophils isolated from mice and human subjects were tested for responses to P. aeruginosa We found that
194 e tested (IE = 19, Control = 18), and n = 36 were tested for responses to sounds (IE = 20, Control =
197 o health facilities in Blantyre, Malawi, and were tested for rotavirus using a VP6 semi-quantitative,
198 In 2000-2012, 10% (n = 45 699) of children were tested for RSV and 16% (n = 11 461) of these tested
199 , chest indrawing, and/or central cyanosis]) were tested for RSV infections using real-time reverse t
200 no vector salivary protein-based vaccine has been tested for safety and immunogenicity in humans.
201 ive participants, 433 (64.8%) had previously been tested for SARS-CoV-2 RNA, and 50.0% had a positive
202 agnostic remnant samples that previously had been tested for SARS-CoV-2, showing that our method not
207 ab, and breastmilk samples from six patients were tested for SARS-CoV-2, and all samples tested negat
208 n = 115) with various severities of COVID-19 were tested for SARS-CoV-2-specific IgG concentrations.
211 criteria of the Villefranche classification were tested for sensitivity (Se), specificity (Sp), posi
212 criteria of the Villefranche classification were tested for sensitivity, specificity, positive and n
213 d scores were recorded, and nasal secretions were tested for shedding of RV-A16 ribonucleic acid.
214 for human pancreatic slices (HPSs) have only been tested for short-term applications, which are not p
217 y-three men treated with docetaxel for mCRPC were tested for somatic BRCA1/2 mutations of the primary
218 erlite XAD-resin as a solid phase extractant was tested for speciation of inorganic mercury, Hg(II) a
219 dvanced to third generation (BC(1):F(3)) and were tested for stability and inheritance of the resista
220 e only leptosporangiate orders that have not been tested for stomatal responses to a low fluence of b
221 ified as P. aeruginosa or Enterobacteriaceae were tested for susceptibility to aztreonam, ceftazidime
222 prepared by wet impregnation method and then were tested for syngas production via dry reforming of m
223 e proportion of MSM who had documentation of being tested for syphilis by their HIV care provider in
225 preclinical models in which new drugs could be tested for target engagement and anti-tumor efficacy.
226 obtained, whether infections other than HIV are tested for, test accuracy, the cost of the test, the
227 ingle quadrupole mass spectrometry (MS) have been tested for the determination of volatile components
229 ndia with no safety signal, and is currently being tested for the first time on the African continent
234 TS assays and a suitable statistical program was tested for the prediction of EC(50) values of Kyoho
237 egrity but with no known antiviral activity, were tested for the ability to inhibit multiple diverse
238 C) parameters and arterial tumor enhancement were tested for the characterization of gastroendopancre
241 C patients in clinical trials with P-AscH(-) were tested for the presence and quantity of circulating
242 P. vivax (n = 18) or P. falciparum (n = 18), were tested for the presence of antibodies to the circum
245 upernatants, as well as paired serum samples were tested for the presence of HLA antibodies using lum
248 phonium ion, and G0 polyamidoamine dendrimer are tested for their ability to inhibit the heptameric a
249 ecome so great that new antimicrobial agents are tested for their capacity of targeting c-di-GMP sign
250 ding cleft, upon which the peptide C termini are tested for their capacity to dislodge the tapasin sc
251 tion or modulate the immune response, should be tested for their effects on hepatocarcinogenesis.
252 thophysiological relevance, but also need to be tested for their robustness across different preserva
253 Invariant natural killer T (iNKT) cells have been tested for their potential use in cancer immune the
256 on-specific effects of some vaccines are now being tested for their ability to protect against COVID-
259 xidant methods, based on chemical reactions, were tested for their ability in anticipating the reduct
261 s in the model grass Brachypodium distachyon were tested for their ability to complement Arabidopsis
262 inomucor elegans and Umbelopsis isabellina), were tested for their ability to enrich white grape poma
263 ergenic Cyp c 1 mutant mouse and rabbit sera were tested for their ability to inhibit IgE recognition
265 simplifying assumptions, and all five models were tested for their ability to predict nitrate concent
266 of the Ir[TpCF(3)PC)]L(2) derivatives, which were tested for their ability to sensitize singlet oxyge
267 Subsequently, nisin-loaded microemulsions were tested for their antimicrobial activity against Lac
269 Loci identified in the discovery analysis were tested for their association with alcohol-related c
271 extract and its major constituent chemicals were tested for their cytotoxicity by colony formation a
272 nymous mutations in reactive T cell epitopes were tested for their effect on the size of the T cell r
273 tasets containing a total of 340 individuals were tested for their genetic structure and degree of in
279 e sagS, or its two variants D105A and L154A, were tested for their potential to form biofilms and cau
283 CT with (68)Ga-DOTA-somatostatin analogs has been tested for therapy monitoring in patients with neur
286 + rituximab with or without plasma exchange were tested for total IgG and IgG1-4 by ELISA, anti-HLA-
287 e scFv scaffold, that allows the same CAR to be tested for toxicity in mice and efficacy against mous
289 whom data were available were HIV-positive) were tested for tuberculosis with Xpert MTB/RIF (Xpert g
291 the mouse hotel, temperature and anesthesia were tested for uniformity in conjunction with (18)F-FDG
292 STIs was assessed in women from whom samples were tested for vaginitis using a molecular diagnostic a
293 l molecules that target BET bromodomains are being tested for various diseases but typically do not d
294 ct HIV spread, and generalized linear models were tested for viral factors associated with dispersal.
295 Participants presenting with febrile illness were tested for virologically confirmed dengue (VCD) by
296 Participants presenting with febrile illness were tested for virologically confirmed dengue by seroty
298 ibitors of the Wnt/beta-catenin pathway have been tested for Wnt-dependent cancers including colorect
299 pools containing a total of 5,518 mosquitoes were tested for YFV by quantitative RT-PCR, immunohistoc
300 01 March 2016-23 August 2017), urine samples were tested for ZIKV by RT-PCR from all women attending